Learn more about whether The Chemours Company or Olin Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The company's diversification strategy has played a key role in witnessing consistent and stable growth in the subdued demand scenario, he added. Epigral's board has approved doubling its CPVC Resin ...
Epigral Ltd. reported a more than 2x jump in Q3 net profit to Rs 103.63 crore driven by strong sales growth. Total income rose 37% YoY to Rs 649.10 crore.